Fundraising FoxPyramid Bioscience
Waltham, US · Founded 2015 · 2 known investors
Find your way into Pyramid Bioscience
Sign up to see every warm intro you have to Pyramid Bioscience
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pyramid Bioscience team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Investors · 2
Reported raises · per SEC filings
Form D private placements$52M disclosed across 5 rounds · 2016–2021
▶$33.5MraisedOct 2021 · 56 investors · BiotechnologyRule 506(b)
▶$33.5MraisedOct 2021 · 56 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry FeinbergDirector
- Vladimir CoricDirector
- Jordan LeefExecutive Officer, Director
- John ChildsDirector
- Kollol PalExecutive Officer, Director
- Amount sold
- $33.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.8MraisedAug 2020 · 48 investors · BiotechnologyRule 506(b)
▶$8.8MraisedAug 2020 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John ChildsDirector
- Vladimir CoricDirector
- Kollol PalExecutive Officer, Director
- Jordan LeefExecutive Officer, Director
- Offering amount
- $18M
- Amount sold
- $8.8M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.6MraisedJul 2020 · 50 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJul 2020 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jordan LeefExecutive Officer, Director
- Kollol PalExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.6M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$6MraisedJul 2020 · 103 investors · BiotechnologyRule 506(b)
▶$6MraisedJul 2020 · 103 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kollol PalExecutive Officer, Director
- Jordan LeefExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$17.3KraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$17.3KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kollol PalExecutive Officer, Director
- Offering amount
- $17.3K
- Amount sold
- $17.3K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Pyramid Bioscience's investors?
- Pyramid Bioscience's investors include Alpine Meridian, Boston Harbor Angels.
- How much funding has Pyramid Bioscience raised?
- Pyramid Bioscience has disclosed $52M raised across 5 rounds.
- Where is Pyramid Bioscience headquartered?
- Pyramid Bioscience is headquartered in Waltham, US.